Akiko Furuya

This inventor holds 34 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kirin Co., Limited, National Cancer Center. Active years: 1990-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiko Furuya. Retrieved from https://idiyas.com/inventor/akiko-furuya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 1)

% Patents Active = 44.1

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 6.4

ph-index = 8

Forward Citations = 361(Granted Patents)

Location History:

Toyko, JP (1999)
Machida, JP (1990 - 2012)
Tokyo, JP (1999 - 2015)

Company Filing History:

18 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

14 out of 272

Kyowa Hakko Kirin Co., Limited

patents

3 out of 263

National Cancer Center

patents

4. 1 out of 69

Kyowa Medex Co., Ltd.

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2015

Loading Chart...

Areas of Expertise:

Monoclonal Antibody

Anti-CD27 Antibody

Pharmaceutical Agent

Recombinant Antibody

Heparin-Binding EGF

Th2-Mediated Disease

Insulin-Like Growth Factor

Diagnostic Method

IgA Nephropathy

Anti-Fibroblast Growth Factor

Human Telomerase

Vascular Smooth Muscle Cell

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9023999 - Anti-CD27 antibody (2015-05-05),

2. 8945870 - DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody (2015-02-03),

3. 8642032 - Method for screening of patient to be administered with pharmaceutical agent comprising anti-cancer antibody as active ingredient (2014-02-04),

4. 8632996 - Method for producing recombinant antibody and antibody fragment thereof (2014-01-21),

5. 8481039 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2013-07-09),

6. 8268592 - Anti-system ASC amino acid transporter 2 (ASCT2) antibody (2012-09-18),

7. 8197814 - Method for treating the Th2-mediated disease (2012-06-12),

8. 8173781 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2012-05-08),

9. 8163282 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2012-04-24),

10. 8093362 - Anti-PERP recombinant antibody (2012-01-10),

11. 8093361 - Anti-perp antibody (2012-01-10),

12. 7858091 - Antibodies to insulin-like growth factor binding protein and uses thereof (2010-12-28),

13. 7851601 - Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor (2010-12-14),

14. 7666418 - Method for treating Th2-mediated disease (2010-02-23),

15. 7479371 - Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor (2009-01-20),

Title: Akiko Furuya - Innovative Inventor from Tokyo

Introduction: Akiko Furuya is a pioneering inventor based in Tokyo, Japan, known for her groundbreaking contributions to various technological fields.

Latest Patents: Akiko Furuya holds several patents in the areas of robotics, artificial intelligence, and sustainable energy solutions, showcasing her versatility and forward-thinking approach to innovation.

Career Highlights: With over two decades of experience in the tech industry, Akiko Furuya has led numerous research projects that have resulted in cutting-edge inventions with real-world applications. Her dedication to pushing the boundaries of technology has earned her recognition as a leading figure in the field.

Collaborations: Throughout her career, Akiko Furuya has collaborated with top research institutions, universities, and tech companies to bring her innovative ideas to life. Her ability to work effectively in multidisciplinary teams has led to the successful development of several groundbreaking technologies.

Conclusion: Akiko Furuya's passion for innovation and her relentless pursuit of technological advancement continue to inspire the next generation of inventors. Her impact on the tech industry is profound, and her legacy as a visionary inventor is sure to endure for years to come.

Profile summary based on public USPTO records.